Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival

被引:24
作者
Roviello, Franco [1 ]
Marano, Luigi [1 ]
Ambrosio, Maria Raffaella [2 ,3 ]
Resca, Luca [1 ]
D'Ignazio, Alessia [1 ]
Petrelli, Federica [2 ,3 ]
Petrioli, Roberto [4 ]
Costantini, Maurizio [2 ]
Polom, Karol [5 ]
Macchiarelli, Raffaele [6 ]
Biviano, Ivano [6 ]
Marrelli, Daniele [1 ]
机构
[1] Univ Siena, Unit Gen Surg & Surg Oncol, Dept Med Surg & Neurosci, Str Scotte 4, I-53100 Siena, Italy
[2] Univ Siena, Pathol Unit, Siena, Italy
[3] Azienda USL Toscana Nord Ovest, Pathol Unit, Pisa, Italy
[4] Univ Siena, Med Oncol Unit, Dept Med Surg & Neurosci, Siena, Italy
[5] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland
[6] AOU Senese, Gastroenterol & Operat Endoscopy Unit, Siena, Italy
来源
EJSO | 2022年 / 48卷 / 03期
关键词
Poorly cohesive gastric cancer; Signet ring cell; Diffuse type gastric cancer; Prognosis; Histology; DIFFUSE TYPES; HIGH-RISK; PROGNOSTIC-SIGNIFICANCE; TIME-TREND; CARCINOMA; HISTOLOGY; ADENOCARCINOMA; EPIDEMIOLOGY; RESECTION; FINLAND;
D O I
10.1016/j.ejso.2021.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and objectives: Signet ring cells (SRC) are widely acknowledged as a prognostically unfavorable histotype amongst poorly cohesive gastric cancer. In this study we evaluated the impact of SRC percentage on the clinical, pathological and prognostic features of these tumors according to the classification by the European Chapter of the IGCA. Methods: We retrospectively reviewed records of patients with poorly cohesive gastric cancer that underwent surgery between 1995 and 2016, whose tissue specimens were available in a biological bank. All slides were put under revision, patients were reclassified into three groups according to the proportion of signet ring cells: "pure" SRC (containing >90% of SRCs), Poorly Cohesive-Not Otherwise Specified (PC -NOS) (containing <10% of SRCs), and PC-NOS/SRC (containing <90% but >10% of SRCs). The clinicopathological factors between different types were analyzed and prognostic differences were compared. Results: Among 143 enrolled patients, 51% were male and 49% were female. The mean (+/- SD) age at diagnosis was 61 +/- 13.9 years. Eighty-seven patients (60.8%) were reclassified as PC-NOS, 56 (39.2%) as PC-NOS/SRC and none as "pure" SRC. Five-years overall survival was significantly higher in PC-NOS/SRC group (63.3%) compared with PC-NOS group (12.7%). The increase in mortality risk was more than fourfold in patients with PC-NOS pattern compared to those with PC-NOS/SRC (HR 4.32 [95% CI 2.5-7.4]. After adjustment for potential confounding factors, SRC pattern was still an independent predictor of survival. Conclusions: The percentage of SRCs is inversely related to tumor aggressiveness, confirming the role of SRC pattern as an independent predictor of survival. (c) 2021 Elsevier Ltd, BASO - The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 46 条
[1]   Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Goetze, Thorsten O. ;
Meiler, Johannes ;
Kasper, Stefan ;
Kopp, Hans-Georg ;
Mayer, Frank ;
Haag, Georg Martin ;
Luley, Kim ;
Lindig, Udo ;
Schmiegel, Wolff ;
Pohl, Michael ;
Stoehlmacher, Jan ;
Folprecht, Gunnar ;
Probst, Stephan ;
Prasnikar, Nicole ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Trojan, Joerg ;
Koenigsmann, Michael ;
Martens, Uwe M. ;
Thuss-Patience, Peter ;
Egger, Matthias ;
Block, Andreas ;
Heinemann, Volker ;
Illerhaus, Gerald ;
Moehler, Markus ;
Schenk, Michael ;
Kullmann, Frank ;
Behringer, Dirk M. ;
Heike, Michael ;
Pink, Daniel ;
Teschendorf, Christian ;
Loehr, Carmen ;
Bernhard, Helga ;
Schuch, Gunter ;
Rethwisch, Volker ;
von Weikersthal, Ludwig Fischer ;
Hartmann, Joerg T. ;
Kneba, Michael ;
Daum, Severin ;
Schulmann, Karsten ;
Weniger, Joerg ;
Belle, Sebastian ;
Gaiser, Timo ;
Oduncu, Fuat S. ;
Guentner, Martina ;
Hozaeel, Wael ;
Reichart, Alexander .
LANCET, 2019, 393 (10184) :1948-1957
[2]  
AMOROSI A, 1994, CANCER, V73, P1533, DOI 10.1002/1097-0142(19940301)73:5<1533::AID-CNCR2820730535>3.0.CO
[3]  
2-J
[4]  
[Anonymous], 2003, JMAJ
[5]   Where does signet-ring cell carcinoma come from and where does it go? [J].
Arai, Tomio .
GASTRIC CANCER, 2019, 22 (04) :651-652
[6]   Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma [J].
Bamboat, Zubin M. ;
Tang, Laura H. ;
Vinuela, Eduardo ;
Kuk, Deborah ;
Gonen, Mithat ;
Shah, Manish A. ;
Brennan, Murray F. ;
Coit, Daniel G. ;
Strong, Vivian E. .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) :1678-1685
[7]   Comprehensive molecular characterization of gastric adenocarcinoma [J].
Bass, Adam J. ;
Thorsson, Vesteinn ;
Shmulevich, Ilya ;
Reynolds, Sheila M. ;
Miller, Michael ;
Bernard, Brady ;
Hinoue, Toshinori ;
Laird, Peter W. ;
Curtis, Christina ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Weinhold, Nils ;
Keiser, David P. ;
Bowlby, Reanne ;
Sipahimalani, Payal ;
Cherniack, Andrew D. ;
Getz, Gad ;
Liu, Yingchun ;
Noble, Michael S. ;
Pedamallu, Chandra ;
Sougnez, Carrie ;
Taylor-Weiner, Amaro ;
Akbani, Rehan ;
Lee, Ju-Seog ;
Liu, Wenbin ;
Mills, Gordon B. ;
Yang, Da ;
Zhang, Wei ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Gulley, Margaret ;
Piazuelo, M. Blanca ;
Schneider, Barbara G. ;
Kim, Jihun ;
Boussioutas, Alex ;
Sheth, Margi ;
Demchok, John A. ;
Rabkin, Charles S. ;
Willis, Joseph E. ;
Ng, Sam ;
Garman, Katherine ;
Beer, David G. ;
Pennathur, Arjun ;
Raphael, Benjamin J. ;
Wu, Hsin-Ta ;
Odze, Robert ;
Kim, Hark K. ;
Bowen, Jay .
NATURE, 2014, 513 (7517) :202-209
[8]  
Bencivenga M, 2020, J SURG ONCOL, P1
[9]  
BOLLSCHWEILER E, 1993, CANCER-AM CANCER SOC, V71, P2918, DOI 10.1002/1097-0142(19930515)71:10<2918::AID-CNCR2820711006>3.0.CO
[10]  
2-V